Cross-cultural psychopharmacology: A current clinical perspective

Psychiatric Services

Volumn 56, Issue 1, 2005, Pages 31-33

  Pi, Edmond H ^a,b   Simpson, George M ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; OROSOMUCOID; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

AGRANULOCYTOSIS; BIOLOGICAL ACTIVITY; CONTROLLED DRUG RELEASE; CULTURAL ANTHROPOLOGY; CULTURAL FACTOR; DIET; DRUG BINDING SITE; DRUG MEGADOSE; DRUG METABOLISM; DRUG USE; ENVIRONMENTAL FACTOR; ETHNOLOGY; EXTRAPYRAMIDAL SYNDROME; GENETIC POLYMORPHISM; HEALTH CARE COST; HUMAN; HYPERGLYCEMIA; LOW DRUG DOSE; MAINTENANCE DRUG DOSE; MENTAL DISEASE; PATIENT COMPLIANCE; PHARMACODYNAMICS; PRESCRIPTION; PROTEIN BLOOD LEVEL; PSYCHOPHARMACOLOGY; RACE DIFFERENCE; SCHIZOPHRENIA; SHORT SURVEY; SIDE EFFECT; SOCIAL PSYCHOLOGY; TARDIVE DYSKINESIA;

CARRIER PROTEINS; CROSS-CULTURAL COMPARISON; ETHNIC GROUPS; HUMANS; MENTAL DISORDERS; PHARMACOKINETICS; PSYCHOPHARMACOLOGY;

EID: 11844254454     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.56.1.31     Document Type: Short Survey

References (31)

1. Lawson WB: Racial and ethnic factors in psychiatric research. Hospital and Community Psychiatry 37:50-54, 1986
2. Segal SP, Bola JR, Watson MA: Race, quality of care, and antipsychotic prescribing practices in psychiatric emergency services. Psychiatric Services 47:282-286, 1996
3. Melfi CA, Croghan TW, Hanna MP, et al: Racial variation in antidepressant treatment in a Medicaid population. Journal of Clinical Psychiatry 61:16-21, 2000
4. Kuno E, Rothbard AB: Racial disparities in antipsychotic prescription patterns for patients with schizophrenia. American Journal of Psychiatry 159:567-572, 2002
5. Copeland LA, Zeber JE, Valenstein M, et al: Racial disparity in the use of atypical antipsychotic medications among veterans. American Journal of Psychiatry 160:1817-1822, 2003
6. Herbeck DM, West JC, Ruditis I, et al: Variations in use of second-generation antipsychotic medication by race among adult psychiatric patients. Psychiatric Services 55:677-684, 2004
7. Lin KM, Finder E: Neuroleptic dosage for Asians. American Journal of Psychiatry 140:490-491, 1983
8. Collazo Y, Tam R, Sramek JJ, et al: Neuroleptic dosing in Hispanic and Asian inpatients with schizophrenia. Mt Sinai Journal of Medicine 63:310-313, 1996
9. Adams GL, Dworkin RJ, Rosenberg SD: Diagnosis and pharmacotherapy issues in the care of Hispanics in the public sector. American Journal of Psychiatry 141:970-974, 1984
10. Sramek JJ, Sayles MA, Simpson GM: Neuroleptic dosage for Asians: a failure to replicate. American Journal of Psychiatry 143:535-536, 1986
11. Carroll RS, Miller A, Ross B, et al: Research as an impetus to improve treatment. Archives of General Psychiatry 37:377-380, 1980
12. Bell CC: Pimping the African-American community. Psychiatric Services 47:1025, 1996
13. Walkup JT, McAlpine DD, Olfson M, et al: Patients with schizophrenia at risk for excessive antipsychotic dosing. Journal of Clinical Psychiatry 61:344-348, 2000
14. Price N, Glazer W, Morgenstern H: Demographic predictors of the use of injectable versus oral antipsychotic medications in outpatients. American Journal of Psychiatry 142:1491-1492, 1985
15. Taylor DM: Prescribing of clozapine and olanzapine: dosage, polypharmacy, and patient ethnicity. Psychiatric Bulletin 28:241-243, 2004
16. Lin KM, Poland RE, Nuccio I, et al: A longitudinal assessment of haloperidol dose and serum concentrations in Asian and Caucasian schizophrenic patients. American Journal of Psychiatry 146:1307-1311, 1989
17. Morgenstern H, Glazer WM: Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications: results of the Yale Tardive Dyskinesia Study. Archives of General Psychiatry 50:723-733, 1993
18. Jeste DV, Caligiuri MP, Paulsen JS: Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 patients. Archives of General Psychiatry 52:756-765, 1995
19. Lawson WB: The art and science of the psychopharmacotherapy of African Americans. Mt Sinai Journal of Medicine 63:301-305, 1996
20. Gray GE, Pi EH: Ethnicity and psychotropic medication related movement disorders. Journal of Practical Psychiatry and Behavioral Health 4:259-264, 1998
21. Pi EH, Simpson GM: Medication-induced movement disorder, in Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 7th ed. Edited by Sadock BJ, Sadock VA, Philadelphia, Lippincott Williams and Wilkins, 2000
22. Pi EH, Gray GE: A cross-cultural perspective on psychopharmacology. Essential Psychopharmacology 2:233-262, 1998
23. Zhou HH, Adedoyin A, Wilkinson GR: Differences in plasma binding of drugs between Caucasians and Chinese subjects. Clinical Pharmacology and Therapeutics 48:10-17, 1990
24. Gonzalez FJ: Human cytochromes P450: problem and prospects. Trends and Pharmacology Science Review 13:346-352, 1992
25. Kalow W: Pharmacogenetics: its biologic roots and the medical challenge. Clinical Pharmacology and Therapeutics 54:235-241, 1993
26. Frackiewicz EJ, Sramek JJ, Herrera J, et al: Ethnicity and antipsychotic response. Annals of Pharmacotherapy 31:1360-1369, 1997
27. Wang PS, Zarin DA, Wet JC, et al: Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia spectrum disorders. Schizophrenia Bulletin 26:451-457, 2002
28. Phillips KA, Mayer ML, Aday LA: Barriers to care among racial/ethnic groups under managed care. Health Affairs 19:65-75, 2000
29. Dolder CR, Lacro JP, Dunn LB, et al: Antipsychotic medication adherence: is there a difference between typical an atypical agents. American Journal of Psychiatry 159:514, 2002
30. Sramek JJ, Pi EH: Antidepressant response in ethnic populations, in Cross Cultural Psychiatry. Edited by Herrera JM, Lawson WB, Sramek JJ. New York, John Wiley and Sons, 1999
31. Simpson GM, Pi EH, Sramek JJ: Neuroleptics and antipsychotic drugs, in Meyler's Side Effects of Drugs, 14th ed. Edited by Dukes MNG. Amsterdam, Netherlands, Exerpta Medica Tertiary-Publications, 2000